<DOC>
	<DOCNO>NCT01046110</DOCNO>
	<brief_summary>This trial conduct Africa , Asia , North America South America . The aim clinical trial compare NN1250 ( insulin degludec ) sitagliptin , add-on subject 's current oral antidiabetic ( OAD ) treatment , subject type 2 diabetes inadequately control 1-2 OADs ( metformin , sulphonylurea , glinides pioglitazone ) .</brief_summary>
	<brief_title>Comparison NN1250 With Sitagliptin Subjects With Type 2 Diabetes Never Treated With Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Type 2 diabetes ( diagnose clinically ) least 6 month Ongoing treatment 1 2 follow OADs ( metformin , insulin secretagogue ( sulphonylurea glinides ) pioglitazone ) combination unchanged dose least 3 month prior Visit 1 minimum dos state : Metformin : alone combination ( include fix combination ) 1500 mg maximum tolerate dose ( least 1000 mg daily ) Insulin secretagogue ( sulfonylurea glinide ) : minimum half maximal daily dose accord local label Pioglitazone : minimum half maximal daily dose accord local labelling maximum tolerate dose Body Mass Index ( BMI ) equal 40.0 kg/m^2 HbA1c 7.511.0 % ( inclusive ) central laboratory analysis Use within last 3 month prior Visit 1 : exenatide , liraglutide , rosiglitazone acarbose Cardiovascular disease , within last 6 month prior Visit 1 , define : stroke ; decompensated heart failure New York Heart Association ( NYHA ) class III IV ; myocardial infarction ; unstable angina pectoris ; coronary arterial bypass graft angioplasty Uncontrolled treated/untreated severe hypertension ( systolic blood pressure least 180 millimetre ( mm ) mercury ( Hg ) and/or diastolic blood pressure least 100 mmHg ) Recurrent severe hypoglycaemia ( 1 severe hypoglycaemic event last 12 month ) hypoglycaemic unawareness judge Investigator hospitalisation diabetic ketoacidosis previous 6 month Pregnancy , breastfeeding , intention become pregnant use adequate Cancer medical history hereof ( except basal cell skin cancer squamous cell skin cancer )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>